We use cookies to give you the best possible experience with eirhub.eu. Some are essential for this site to function; others help us understand how you use the site, so we can improve it. We may also use cookies for targeting purposes. Click “Accept all cookies” to proceed as specified, or click “Manage my preferences” to choose the types of cookies you will accept. Cookie policy
Privacy Preference Center
Eirhub and our trusted partners use cookies and similar technologies to access and use your data for the purposes listed below. Please provide your consent for cookie usage on this website. Enable one or more of the cookie types listed below, and then save your preferences. Cookie policy
Manage Consent Preferences
Performance Cookies
on
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Active (Inactive)
Functional Cookies
off
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. Active (Inactive)
Targeting Cookies
off
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Active (Inactive)
Strictly Necessary Cookies
on
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. Always Active

Market Access Feasibility Assessment

Task:
Assess market potential, epidemiology, and treatment landscape
Task:
Assess market potential, epidemiology, and treatment landscape
Client:
British pharmaceutics company
Region:
Ukraine, Armenia, Azerbaijan, Georgia, Kazakhstan, Uzbekistan + 2 other countries
Project scope:
  • Assessment of the possibility for the Target product of getting the status of an orphan drug for three indications—Lennox-Gastaut-Syndrome, Dravet Syndrome, and Tuberous Sclerosis.
  • Analysis of disease management and treatment practices in countries from the scope.
  • Outlining patient flows for three indications in all countries.
  • Analysis of the market landscape, competitive products within the therapeutic areas, and prescription patterns.
  • Pricing analysis of products prescribed within the three indications.
  • The decision-making process for innovative products in all countries.
  • Available pathways for early access (if possible).
Indications in focus:

Neurology / Epilepsy:

  • Lennox-Gastaut-Syndrome
  • Dravet Syndrome
  • Tuberous Sclerosis
Deliverables:
  • A comprehensive report covering 8 countries and three indications.


Project
leads

Yevgen Brovko
Co-founder, Market Access Partner (Pharmac/Biopharma, MedTech, Digital Health)
Anastasiia Havrysh
Market Access Manager (Pharma, MedTech, Digital Health)
Valentyna Khomenko
Market Access Specialist
Download
our Brochure